Using cold and liquid ventilation to reduce the risk of after-effects following cardiac arrest: Researchers from ENVA, UPEC, Inserm and the Mondor Institute are at the forefront of this new technique.
46,000 people suffer cardiac arrest every year in France. Researchers from EnvA, the University of Paris Est Créteil, Inserm and the Mondor Institute for Biomedical Research, including Professor Renaud Tissier (Bijan Ghaleh team), and also Professor Philippe Micheau from the University of Sherbrooke in Canada, are proposing a new approach to better manage them and better understand their possible consequences. It is based on a technique based on cold and liquid ventilation that allows the body to be in hypothermia in 20 minutes instead of three to six hours with the usual techniques.
Blood circulation and the body’s needs will be considerably reduced, thus limiting the risk of after-effects. The results of this work are described in an article on the EBioMedicine website and will be published in the next issue in January 2020.
POSTPONED : (Pending title) :
«Peter Currie - 12h – Amphi 5, 4ème étage de la Faculté de Médecine»
POSTPONED : Matrix therapy and mimetics of Heparan sulfate a new branch of regenerative medicine : from concept to product and from bench to patient. A 30 years saga that was born at UPEC. :
«Denis Barritault - 12h – Amphi 5, 4ème étage de la Faculté de Médecine de Créteil»
POSTPONED : Journal Club Multi-thématique : (upcoming title) :
«Cécile Naït-Meddour - 12h – Salle 3058, 3ème étage de la Faculté de Médecine de Créteil»
All incoming seminars